News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Proteome Therapeutics Corporation and Atreus Pharmaceuticals, Inc. Announce Strategic R&D Agreement


11/5/2007 12:21:48 PM

BOSTON, MASSACHUSETTS--(Marketwire - November 05, 2007) - Advanced Proteome Therapeutics Inc. - (APT), a subsidiary of Advanced Proteome Therapeutics Corporation (TSX VENTURE: APC) and Atreus Pharmaceuticals, Inc. (Atreus) today announced they have entered into a strategic research and development agreement to explore the development of novel protein - in vivo imaging agents using advanced site-directed peptide modification techniques developed by APT.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES